"Baylor Scott & White All Saints Medical Center - Fort Worth is a full-service hospital serving patients in and around Fort Worth. Open 24 hours a day, every day, the specialists at the medical center provide care to patients in the areas of allergy and immunology, ENT, back pain, imaging, cancer care, heart condition, dermatology, surgery, urology, wound care, and more."

During the past decade, Baylor All Saints Medical Center at Fort Worth conducted 28 clinical trials. In the 10-year time frame, 28 clinical trials started and 28 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 17 clinical trials were completed. i.e. 188.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Baylor All Saints Medical Center at Fort Worth" #1 sponsor was "National Cancer Institute (NCI)" with 7 trials, followed by "Abbott Medical Devices" with 5 trials sponsored, "Gynecologic Oncology Group" with 5 trials sponsored, "Conatus Pharmaceuticals Inc." with 4 trials sponsored and "Gilead Sciences" with 4 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Baylor All Saints Medical Center at Fort Worth" #1 collaborator was "National Cancer Institute (NCI)" with 7 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "Biosense Webster, Inc." with 2 trials as a collaborator, "Abbott Medical Devices" with 1 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Baylor All Saints Medical Center at Fort Worth" are "Recurrent Fallopian Tube Carcinoma" (6 trials), "Recurrent Ovarian Carcinoma" (6 trials), "Recurrent Primary Peritoneal Carcinoma" (6 trials), "COVID-19" (4 trials) and "Hepatorenal Syndrome" (4 trials). Many other conditions were trialed in "Baylor All Saints Medical Center at Fort Worth" in a lesser frequency.

Most popular intervention types in "Baylor All Saints Medical Center at Fort Worth" are "Drug" (37 trials), "Other" (19 trials), "Device" (11 trials), "Biological" (8 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Laboratory Biomarker Analysis" (12 trials), "Paclitaxel" (6 trials), "Quality-of-Life Assessment" (6 trials) and "Bevacizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Baylor All Saints Medical Center at Fort Worth" are 38 trials for "All" genders and 17 trials for "Female" genders.

Currently, there are NaN active trials in "Baylor All Saints Medical Center at Fort Worth". undefined are not yet recruiting, 3 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 34 completed trials in Baylor All Saints Medical Center at Fort Worth, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Baylor All Saints Medical Center at Fort Worth, 2 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 7 trials that are defined as “Not Applicable".